Literature DB >> 10983521

Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling.

K D Thrall1, M E Vucelick, R A Gies, R C Zangar, K K Weitz, T S Poet, D L Springer, D M Grant, J M Benson.   

Abstract

No study has comprehensively compared the rate of metabolism of carbon tetrachloride (CCl4) across species. Therefore, the in vivo metabolism of CCl4 was evaluated using groups of male animals (F344 rats, B6C3F1 mice, and Syrian hamsters) exposed to 40-1800 ppm CCl4 in a closed, recirculating gas-uptake system. For each species, an optimal fit of the family of uptake curves was obtained by adjusting Michaelis-Menten metabolic constants Km (affinity) and Vmax (capacity) using a physiologically based pharmacokinetic (PBPK) model. The results show that the mouse has a slightly higher capacity and lower affinity for metabolizing CCl4 compared to the rat, while the hamster has a higher capacity and lower affinity than either rat or mouse. A comparison of the Vmax to Km ratio, normalized for milligrams of liver protein (L/h/mg) across species, indicates that hamsters metabolize more CCl4 than either rats or mice, and should be more susceptible to CCl4-induced hepatotoxicity. These species comparisons were evaluated against toxicokinetic studies conducted in animals exposed by nose-only inhalation to 20 ppm 14C-labeled CCl4 for 4 h. The toxicokinetic study results are consistent with the in vivo rates of metabolism, with rats eliminating less radioactivity associated with metabolism (14CO2 and urine/feces) and more radioactivity associated with the parent compound (radioactivity trapped on charcoal) compared to either hamsters or mice. The in vivo metabolic constants determined here, together with in vitro constants determined using rat, mouse, hamster, and human liver microsomes, were used to estimate human in vivo metabolic rates of 1.49 mg/h/kg body weight and 0.25 mg/L for Vmax and Km, respectively. Normalizing the rate of metabolism (Vmax/Km) by milligrams liver protein, the rate of metabolism of CCl4 differs across species, with hamster > mouse > rat > human.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983521     DOI: 10.1080/00984100050082085

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  14 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.

Authors:  Lisa M Sweeney; Laura MacCalman; Lynne T Haber; Eileen D Kuempel; C Lang Tran
Journal:  Regul Toxicol Pharmacol       Date:  2015-07-03       Impact factor: 3.271

3.  Effects of melatonin on carbon tetrachloride-induced changes in rat serum.

Authors:  M Ogeturk; I Kus; A Kavakli; I Zararsiz; N Ilhan; M Sarsilmaz
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

Review 4.  Animal models of drug-induced liver injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-03       Impact factor: 5.187

5.  Fluoxetine-induced decrements in sexual responses of female rats and hamsters are reversed by 3α,5α-THP.

Authors:  Cheryl A Frye; Madeline E Rhodes
Journal:  J Sex Med       Date:  2010-04-20       Impact factor: 3.802

Review 6.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

7.  Vitamin D and melatonin protect the cell's viability and ameliorate the CCl4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell lines.

Authors:  Dilşad Özerkan; Nesrin Özsoy; Erkan Yılmaz
Journal:  Cytotechnology       Date:  2014-07-06       Impact factor: 2.058

Review 8.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

9.  Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).

Authors:  M Moiz Mumtaz; Meredith Ray; Susan R Crowell; Deborah Keys; Jeffrey Fisher; Patricia Ruiz
Journal:  J Toxicol Environ Health A       Date:  2012

Review 10.  Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants.

Authors:  Patricia Ruiz; Meredith Ray; Jeffrey Fisher; Moiz Mumtaz
Journal:  Int J Mol Sci       Date:  2011-10-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.